19126193

Source:http://linkedlifedata.com/resource/pubmed/id/19126193

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0016884, umls-concept:C0026769, umls-concept:C0035647, umls-concept:C0150369, umls-concept:C0237876, umls-concept:C1274040, umls-concept:C1519193
pubmed:dateCreated	2009-1-28
pubmed:abstractText	Risk sharing schemes represent an innovative and important approach to the problems of rationing and achieving cost-effectiveness in high cost or controversial health interventions. This study aimed to assess the feasibility of risk sharing schemes, looking at long term clinical outcomes, to determine the price at which high cost treatments would be acceptable to the NHS.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19126193-12586677, http://linkedlifedata.com/resource/pubmed/commentcorrection/19126193-12598138, http://linkedlifedata.com/resource/pubmed/commentcorrection/19126193-12623909, http://linkedlifedata.com/resource/pubmed/commentcorrection/19126193-16434648, http://linkedlifedata.com/resource/pubmed/commentcorrection/19126193-16437558, http://linkedlifedata.com/resource/pubmed/commentcorrection/19126193-17052660, http://linkedlifedata.com/resource/pubmed/commentcorrection/19126193-2043940, http://linkedlifedata.com/resource/pubmed/commentcorrection/19126193-6685237, http://linkedlifedata.com/resource/pubmed/commentcorrection/19126193-7558554
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100968555
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Immunologic Factors, http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-beta, http://linkedlifedata.com/resource/pubmed/chemical/Peptides, http://linkedlifedata.com/resource/pubmed/chemical/copolymer 1
pubmed:status	MEDLINE
pubmed:issn	1471-2377
pubmed:author	pubmed-author:AbramsKeith RKR, pubmed-author:BoggildMikeM, pubmed-author:ChaterTimothyT, pubmed-author:ChilcottJames BJB, pubmed-author:CooperCindy LCL, pubmed-author:CooperNicola JNJ, pubmed-author:EbersGeorgeG, pubmed-author:NichollJonJ, pubmed-author:O'HaganAnthonyA, pubmed-author:PalaceJackieJ, pubmed-author:PickinMarkM, pubmed-author:TappendenPaulP
pubmed:issnType	Electronic
pubmed:volume	9
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:19126193-Adult, pubmed-meshheading:19126193-Cost-Benefit Analysis, pubmed-meshheading:19126193-Female, pubmed-meshheading:19126193-Follow-Up Studies, pubmed-meshheading:19126193-Great Britain, pubmed-meshheading:19126193-Health Care Costs, pubmed-meshheading:19126193-Humans, pubmed-meshheading:19126193-Immunologic Factors, pubmed-meshheading:19126193-Immunosuppressive Agents, pubmed-meshheading:19126193-Interferon-beta, pubmed-meshheading:19126193-Male, pubmed-meshheading:19126193-Middle Aged, pubmed-meshheading:19126193-Multiple Sclerosis, pubmed-meshheading:19126193-Organizational Case Studies, pubmed-meshheading:19126193-Outcome Assessment (Health Care), pubmed-meshheading:19126193-Peptides, pubmed-meshheading:19126193-Prospective Studies, pubmed-meshheading:19126193-Risk Sharing, Financial
pubmed:year	2009
pubmed:articleTitle	The Multiple Sclerosis Risk Sharing Scheme Monitoring Study--early results and lessons for the future.
pubmed:affiliation	Medical Care Research Unit, School of Health and Related Research, University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, UK. d.m.pickin@sheffield.ac.uk
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study